Marshall Wace North America’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $290K | Buy |
+6,028
| New | +$290K | ﹤0.01% | 1200 |
|
|
2020
Q2 | – | Sell |
-17,798
| Closed | -$536K | – | 1374 |
|
|
2020
Q1 | $536K | Buy |
+17,798
| New | +$536K | ﹤0.01% | 745 |
|
|
2019
Q1 | – | Sell |
-44,846
| Closed | -$1.03M | – | 1795 |
|
|
2018
Q4 | $1.03M | Buy |
+44,846
| New | +$1.03M | 0.01% | 606 |
|
|
2018
Q3 | – | Sell |
-71,194
| Closed | -$1.64M | – | 1230 |
|
|
2018
Q2 | $1.64M | Sell |
71,194
-318,782
| -82% | -$7.35M | 0.01% | 816 |
|
|
2018
Q1 | $9.6M | Buy |
+389,976
| New | +$9.6M | 0.05% | 406 |
|
|
2017
Q2 | – | Sell |
-1,023,836
| Closed | -$17.4M | – | 1407 |
|
|
2017
Q1 | $17.4M | Buy |
+1,023,836
| New | +$17.4M | 0.14% | 190 |
|